Abstract: Methods, apparatuses, systems, and computer program products for lifetime battery tracking using a wireless interface are disclosed. During production and assembly of a battery pack, the location of a battery module in a production line is tracked using detected signal strengths from a wireless transmitter of a battery module monitoring system. During the life of the battery module, the battery module monitoring system provides battery usage data that can be combined with vehicle data for diagnostic analysis.

Abstract: Methods and apparatuses for a listening only wireless network controller in a wireless battery management system are disclosed. A primary wireless network controller (WNC) receives battery sensor data from a plurality of module monitoring systems (MMSs). A secondary WNC also receives the battery sensor data from the MMSs. The secondary WNC is listening-only, in that it does not send commands to the MMSs. The listening-only WNC may be used to collect and provide redundant data for communication integrity or enhanced data for performance and diagnostic purposes. A collection of listening-only WNCs may be used to map locations of MMSs based on signal strength.

Abstract: Methods and apparatuses for a listening only wireless network controller in a wireless battery management system are disclosed. A primary wireless network controller (WNC) receives battery sensor data from a plurality of module monitoring systems (MMSs). A secondary WNC also receives the battery sensor data from the MMSs. The secondary WNC is listening-only, in that it does not send commands to the MMSs. The listening-only WNC may be used to collect and provide redundant data for communication integrity or enhanced data for performance and diagnostic purposes. A collection of listening-only WNCs may be used to map locations of MMSs based on signal strength.

Abstract: Provided herein are small molecules comprising a first domain that binds to ASH1L and a second domain that facilitates ASH1L degradation. In particular, ASH1L-targeting proteolysis targeting chimeras (PROTACs) and methods of use thereof for the treatment of disease (e.g., acute leukemia, solid cancers and other diseases dependent on activity of ASH1L) are provided.

Abstract: In a particular embodiment, a method of functional safety in a battery management system is disclosed that includes: generating, by a module monitoring system of the battery management system, battery sensor data; generating, by the module monitoring system, based on the battery sensor data, integrity data; sending, by the module monitoring system, via a wireless black communication channel to a wireless network controller of the battery management system, the battery sensor data and the integrity data; and sending, by the wireless network controller, to a vehicle control system, the battery sensor data.

Abstract: The present disclosure provides a pharmaceutical composition comprising a Bcl-2/Bcl-xL inhibitor, a chemotherapeutic agent, and a pharmaceutically acceptable carrier. The present disclosure also provides a method of treating cancer, comprising administering to a subject in need thereof a therapeutically effective amount of a Bcl-2/Bcl-xL inhibitor and a therapeutically effective amount of a chemotherapeutic agent. The present disclosure also provides use of a combination of a Bcl-2/Bcl-xL inhibitor and a chemotherapeutic agent in the manufacture of an anti-tumor medicament. In the present disclosure, a significantly enhanced anti-tumor effect can be achieved by administration of a Bcl-2/Bcl-xL inhibitor in combination with a chemotherapeutic agent.

Abstract: Provided herein are small molecules that bind to ASH1L and inhibit ASH1L activity, and methods of use thereof for the treatment of disease, including acute leukemia, solid cancers and other diseases dependent on activity of ASH1L.

Abstract: According to one embodiment, a system for hybrid communication between electronic circuits is disclosed. The system includes a plurality of sensor nodes configured to read data from one or more sensors. The system also includes a master node configured to receive periodic data transmissions from each of the plurality of sensor nodes via a primary transmission medium and a secondary transmission medium, which is different from the primary transmission medium.

Abstract: Provided herein are small molecules that bind to ASH1L and inhibit ASH1L activity, and methods of use thereof for the treatment of disease, including acute leukemia, solid cancers and other diseases dependent on activity of ASH1L.

Abstract: A method of implementing security in a modular exponentiation function for cryptographic operations is provided. A key is obtained as a parameter when the modular exponentiation function is invoked. The key may be one of either a public key or a private key of a cryptographic key pair. Within the modular exponentiation function, the method ascertains whether the key is greater than L bits long, where L is a positive integer. A countermeasure against an attack is implemented if the key is greater than L bits long. The countermeasure may include one or more techniques (e.g., hardware and/or software techniques) that inhibit or prevent information about the key from being ascertained through analysis. One or more exponentiation operations may then be performed using the key. The same modular exponentiation function may be used to perform encryption and decryption operations but with different keys.

Abstract: Provided herein are small molecules comprising a first domain that binds to ASH1L and a second domain that facilitates ASH1L degradation. In particular, ASH1L-targeting proteolysis targeting chimeras (PROTACs) and methods of use thereof for the treatment of disease (e.g., acute leukemia, solid cancers and other diseases dependent on activity of ASH1L) are provided.

Abstract: Provided herein are small molecules that bind to ASH1L and inhibit ASH1L activity, and methods of use thereof for the treatment of disease, including acute leukemia, solid cancers and other diseases dependent on activity of ASH1L.

Abstract: Embodiments of the present application are directed to an automation process method to generate a set of wetland predictive variables using Light Detection and Ranging (“LiDAR”) data within a geographic information system (“GIS”) software platform, according to some embodiments, and to model and predict wetland in ArcGIS platform using the generated variable set. The automatic process also can run analysis on and display of the predicted wetland. The process is built by developing modules and connection in GIS. The above mentioned processes are automatically run and may just be run by one-button press, or on click, or separate buttons press, or separate clicks.

Abstract: The present invention relates to novel retinoid-related orphan receptor gamma (ROR?) modulators of Formula (I) and their use in the treatment of diseases mediated by ROR?.

Abstract: The present invention relates to novel retinoid-related orphan receptor gamma (ROR?) modulators and their use in the treatment of diseases mediated by ROR?.

Abstract: A method of implementing security in a modular exponentiation function for cryptographic operations is provided. A key is obtained as a parameter when the modular exponentiation function is invoked. The key may be one of either a public key or a private key of a cryptographic key pair. Within the modular exponentiation function, the method ascertains whether the key is greater than L bits long, where L is a positive integer. A countermeasure against an attack is implemented if the key is greater than L bits long. The countermeasure may include one or more techniques (e.g., hardware and/or software techniques) that inhibit or prevent information about the key from being ascertained through analysis. One or more exponentiation operations may then be performed using the key. The same modular exponentiation function may be used to perform encryption and decryption operations but with different keys.

Abstract: A method and system are provided for simultaneously coupling to a plurality of client applications, receiving a first playback request from a first client application of the plurality of client applications, the first playback request being implemented in a first application specific protocol of the first client application, and a second playback request from a second client application of the plurality of client applications, the second playback request being implemented in a second application specific protocol of the second client application, wherein the first application specific protocol is different from the second application specific protocol and executing the first playback request and the second playback request by one or more players implemented in a single protocol.

Abstract: The present invention relates to novel retinoid-related orphan receptor gamma (ROR?) modulators and their use in the treatment of diseases mediated by ROR?.

Abstract: The present invention relates to novel retinoid-related orphan receptor gamma (ROR?) modulators and their use in the treatment of diseases mediated by ROR?.

Abstract: The present invention relates to use of a camptothecin derivative for preparing a medicament for the treatment of multiple myeloma. The medicament is represented by Formula I and can be pharmaceutically acceptable salts thereof. This medicament shows advantages in treatment of multiple myeloma and avoids drug resistance problems for existing drugs.